Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIC-TAC-SAM: Early vs Delayed Etoposide in Severe HLH
NCT07497438Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide in hemophagocytic lymphohistiocytosis (HLH), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
etoposide
03
Conditions
hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT07497438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497438.